AbbVie, Inc. (ABBV)
294.77
+8.77
(+3.07%)
USD |
NYSE |
Nov 04, 16:00
293.01
-1.76
(-0.60%)
After-Hours: 16:28
AbbVie Total Return Price : 294.77 for Nov. 4, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| November 03, 2026 | 286.00 |
| November 02, 2026 | 288.84 |
| October 30, 2026 | 294.89 |
| October 29, 2026 | 290.79 |
| October 28, 2026 | 285.99 |
| October 27, 2026 | 286.39 |
| October 26, 2026 | 286.74 |
| October 23, 2026 | 285.64 |
| October 22, 2026 | 285.19 |
| October 21, 2026 | 284.80 |
| October 20, 2026 | 289.08 |
| October 19, 2026 | 282.68 |
| October 16, 2026 | 285.42 |
| October 15, 2026 | 283.40 |
| October 14, 2026 | 281.75 |
| October 13, 2026 | 272.69 |
| October 12, 2026 | 279.40 |
| October 09, 2026 | 274.78 |
| October 08, 2026 | 270.76 |
| October 07, 2026 | 269.70 |
| October 06, 2026 | 265.06 |
| October 05, 2026 | 264.14 |
| October 02, 2026 | 261.22 |
| October 01, 2026 | 258.34 |
| September 30, 2026 | 259.99 |
| Date | Value |
|---|---|
| September 29, 2026 | 261.68 |
| September 28, 2026 | 264.66 |
| September 25, 2026 | 262.73 |
| September 24, 2026 | 263.50 |
| September 23, 2026 | 263.46 |
| September 22, 2026 | 263.59 |
| September 21, 2026 | 262.87 |
| September 18, 2026 | 262.35 |
| September 17, 2026 | 262.41 |
| September 16, 2026 | 260.91 |
| September 15, 2026 | 261.43 |
| September 14, 2026 | 260.17 |
| September 11, 2026 | 255.55 |
| September 10, 2026 | 253.44 |
| September 09, 2026 | 249.38 |
| September 08, 2026 | 247.26 |
| September 04, 2026 | 254.89 |
| September 03, 2026 | 258.62 |
| September 02, 2026 | 260.12 |
| September 01, 2026 | 258.40 |
| August 31, 2026 | 254.86 |
| August 28, 2026 | 253.92 |
| August 27, 2026 | 256.57 |
| August 26, 2026 | 261.30 |
| August 25, 2026 | 264.17 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Gilead Sciences, Inc. | 174.45 |
| Biogen, Inc. | 254.51 |
| Regeneron Pharmaceuticals, Inc. | 930.74 |
| Amgen, Inc. | 478.34 |
| REGENXBIO, Inc. | 7.74 |